Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sona Nanotech Inc C.SONA

Alternate Symbol(s):  SNANF

Sona Nanotech Inc. is a nanotechnology life sciences company that has developed multiple methods for the manufacturing of various types of gold nanoparticles. The Company is engaged in the research and development of its technology for use in multiplex diagnostic testing platforms and biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of CTAB (cetyltrimethylammonium), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company leverages its core proprietary gold nanorod (GNR) manufacturing technology and laboratory assets to focus on the development of diagnostic tests and biologic reagents, and the advancement of its GNR intellectual property.


CSE:SONA - Post by User

Comment by whatdoiknow123on Sep 29, 2020 4:21pm
168 Views
Post# 31636880

RE:RE:Approvals

RE:RE:Approvals
wallpaper2 wrote:
Can anyone provide a quick pros and cons on the 3 tests awaiting approval.



Very quick because quite busy:

1. QUIDEL  needs machine and so not suitable for Screening. Has had problems with accuracy and still under a little suspicion.

2. ABBOTT  machine free but most work been done on Symptomatic patients with high viral load. Significant doubts about accuracy in lower viral load patients and no evidence on the Asymptomatic.

3. SONA  machine free, lab sensitivity and selectivity very high but less so in in-field testing ( there may however be very good reasons why so but would need time to fully explain) . Very good results in Asymptomatic group which will no doubt be investigated further. Working on saliva test. Very promising for Screening Programmes.

The other 2 are much bigger Companies but SONA has the support of Danaher ( 150 billion market cap) and has, in my and many others´ opinions the better and more versatile test.
<< Previous
Bullboard Posts
Next >>